Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization
- 1 October 2000
- journal article
- symposium i
- Published by Springer Nature in Breast Cancer
- Vol. 7 (4) , 287-296
- https://doi.org/10.1007/bf02966392
Abstract
The purpose of this study was to determine the feasibility of sentinel lymph node (SLN) biopsy using blue dye with or without isotope localization to predict the presence of axillary and internal mammary lymph node (IMN) metastases in patients with breast cancer. We also investigated whether multiple sectioning of the SLN could improve the accuracy of frozen section examination.Keywords
This publication has 45 references indexed in Scilit:
- Credentialing for Breast Lymphatic Mapping: How Many Cases Are Enough?Annals of Surgery, 1999
- Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered11No competing interests declared.Journal of the American College of Surgeons, 1999
- Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of CareNew England Journal of Medicine, 1998
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- The role of internal mammary lymph node metastases in the management of breast cancerBreast Cancer, 1998
- Sentinel Lymph Node Biopsy in Breast Cancer: Initial Experience at Memorial Sloan-Kettering Cancer Center 1Published by Wolters Kluwer Health ,1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patientsEuropean Journal Of Cancer, 1995
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993